The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McRae, J. L.
Right arrow Articles by Gordon, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McRae, J. L.
Right arrow Articles by Gordon, D. L.
The Journal of Immunology, 2005, 174: 6250-6256.
Copyright © 2005 by The American Association of Immunologists

Human Factor H-Related Protein 5 Has Cofactor Activity, Inhibits C3 Convertase Activity, Binds Heparin and C-Reactive Protein, and Associates with Lipoprotein 1

Jennifer L. McRae2,*,{dagger},{ddagger}, Thomas G. Duthy§, Kim M. Griggs§, Rebecca J. Ormsby§, Peter J. Cowan{dagger},{ddagger}, Brett A. Cromer, William J. McKinstry, Michael W. Parker, Brendan F. Murphy*,{dagger},{ddagger} and David L. Gordon§

* Department of Nephrology,{dagger} Immunology Research Centre, and{ddagger} University of Melbourne Department of Medicine, St. Vincent’s Hospital Melbourne, Fitzroy, Victoria, Australia;§ Department of Microbiology and Infectious Diseases, Flinders Medical Centre, Bedford Park, Australia; and St. Vincent’s Institute, Fitzroy, Australia

Factor H-related protein 5 (FHR-5) is a recently discovered member of the factor H (fH)-related protein family. FHR proteins are structurally similar to the complement regulator fH, but their biological functions remain poorly defined. FHR-5 is synthesized in the liver and consists of 9 short consensus repeats (SCRs), which display various degrees of homology to those of fH and the other FHR proteins. FHR-5 colocalizes with complement deposits in vivo and binds C3b in vitro, suggesting a role in complement regulation or localization. The current study examined whether rFHR-5 exhibits properties similar to those of fH, including heparin binding, CRP binding, cofactor activity for the factor I-mediated degradation of C3b and decay acceleration of the C3 convertase. rFHR-5 bound heparin-BSA and heparin-agarose and a defined series of truncations expressed in Pichia pastoris localized the heparin-binding region to within SCRs 5–7. rFHR-5 bound CRP, and this binding was also localized to SCRs 5–7. FHR-5 inhibited alternative pathway C3 convertase activity in a fluid phase assay; however, dissociation of the convertase was not observed in a solid phase assay. rFHR-5 displayed factor I-dependent cofactor activity for C3b cleavage, although it was apparently less effective than fH. In addition, we demonstrate association of FHR-5 with high density lipid lipoprotein complexes in human plasma. These results demonstrate that FHR-5 shares properties of heparin and CRP binding and lipoprotein association with one or more of the other FHRs but is unique among this family of proteins in possessing independent complement-regulatory activity.




This article has been cited by other articles:


Home page
BloodHome page
C. Abarrategui-Garrido, R. Martinez-Barricarte, M. Lopez-Trascasa, S. Rodriguez de Cordoba, and P. Sanchez-Corral
Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome
Blood, November 5, 2009; 114(19): 4261 - 4271.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Inomata, H. Tanihara, M. Tanito, H. Okuyama, Y. Hoshino, T. Kinumi, T. Kawaji, N. Kondo, J. Yodoi, and H. Nakamura
Suppression of Choroidal Neovascularization by Thioredoxin-1 via Interaction with Complement Factor H
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5118 - 5125.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Y. Park, Y. P. Shin, C. H. Kim, H. J. Park, Y. S. Seong, B. S. Kim, S. J. Seo, and I. H. Lee
Immune Evasion of Enterococcus faecalis by an Extracellular Gelatinase That Cleaves C3 and iC3b
J. Immunol., November 1, 2008; 181(9): 6328 - 6336.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. R. Tyson, C. Elkins, and A. M. de Silva
A Novel Mechanism of Complement Inhibition Unmasked by a Tick Salivary Protein That Binds to Properdin
J. Immunol., March 15, 2008; 180(6): 3964 - 3968.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. J. Alexander, Y. Wang, A. Chang, A. Jacob, A. W.M. Minto, M. Karmegam, M. Haas, and R. J. Quigg
Mouse Podocyte Complement Factor H: The Functional Analog to Human Complement Receptor 1
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1157 - 1166.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Schneider, R. M. Exley, H. Chan, I. Feavers, Y.-H. Kang, R. B. Sim, and C. M. Tang
Functional Significance of Factor H Binding to Neisseria meningitidis.
J. Immunol., June 15, 2006; 176(12): 7566 - 7575.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Verma, J. Hellwage, S. Artiushin, P. F. Zipfel, P. Kraiczy, J. F. Timoney, and B. Stevenson
LfhA, a Novel Factor H-Binding Protein of Leptospira interrogans.
Infect. Immun., May 1, 2006; 74(5): 2659 - 2666.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.